ArticleHemaSphere2024

30-Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis.

Enrique M Ocio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.